These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38697235)

  • 1. A Randomized Trial of Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting.
    Mehta SJ; Palat S; McDonald C; Reitz C; Okorie E; Williams K; Tao J; Shaw PA; Glanz K; Asch DA
    Clin Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38697235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
    Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
    JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Behavioral Economics Principles Improves Participation in Mailed Outreach for Colorectal Cancer Screening.
    Bakr O; Afsar-Manesh N; Raja N; Dermenchyan A; Goldstein NJ; Shu SB; May FP
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00115. PubMed ID: 31972609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial.
    Huf SW; Asch DA; Volpp KG; Reitz C; Mehta SJ
    J Gen Intern Med; 2021 Jul; 36(7):1958-1964. PubMed ID: 33511567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equitable Implementation of Mailed Stool Test-Based Colorectal Cancer Screening and Patient Navigation in a Safety Net Health System.
    Scott RE; Chang P; Kluz N; Baykal-Caglar E; Agrawal D; Pignone M
    J Gen Intern Med; 2023 May; 38(7):1631-1637. PubMed ID: 36456842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial.
    Mehta SJ; Pepe RS; Gabler NB; Kanneganti M; Reitz C; Saia C; Teel J; Asch DA; Volpp KG; Doubeni CA
    JAMA Netw Open; 2019 Mar; 2(3):e191156. PubMed ID: 30901053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Text messaging and lottery incentive to improve colorectal cancer screening outreach at a community health center: A randomized controlled trial.
    Mehta SJ; Oyalowo A; Reitz C; Dean O; McAuliffe T; Asch DA; Doubeni CA
    Prev Med Rep; 2020 Sep; 19():101114. PubMed ID: 32477853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial.
    Coronado GD; Leo MC; Ramsey K; Coury J; Petrik AF; Patzel M; Kenzie ES; Thompson JH; Brodt E; Mummadi R; Elder N; Davis MM
    Implement Sci Commun; 2022 Apr; 3(1):42. PubMed ID: 35418107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Controlled Trial of Advance Notification Phone Calls vs Text Messages Prior to Mailed Fecal Test Outreach.
    Coronado GD; Nyongesa DB; Petrik AF; Thompson JH; Escaron AL; Younger B; Harbison S; Leo MC
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2353-2360.e2. PubMed ID: 32739569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a mailed fecal immunochemical test outreach: a Medicare Advantage pilot study.
    Issaka RB; Akinsoto NO; Strait E; Chaudhari V; Flum DR; Inadomi JM
    Therap Adv Gastroenterol; 2020; 13():1756284820945388. PubMed ID: 32952612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial.
    Kapinos KA; Halm EA; Murphy CC; Santini NO; Loewen AC; Skinner CS; Singal AG
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2383-2392.e4. PubMed ID: 35144024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Mailed Fecal Immunochemical Test Completion in an Integrated Academic-Community Healthcare System.
    Simpson S; Yu K; Bell-Brown A; Kimura A; Meisner A; Issaka RB
    Clin Transl Gastroenterol; 2024 Aug; ():. PubMed ID: 39132880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.